Live Chat

Trade Novavax NVAX

Novavax live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2025 Feb 24, 06:17

B. Riley Estimates Novavax's FY2024 Earnings (NASDAQ:NVAX)

Novavax Inc
Webhose 2025 Feb 22, 13:15

B. Riley Predicts Novavax's Q2 Earnings (NASDAQ:NVAX)

Novavax Inc
Webhose 2025 Feb 21, 21:29

Novavax (NASDAQ:NVAX) Trading Up 5.6% - What's Next?

Novavax Inc
Webhose 2025 Feb 21, 19:50

Novavax call volume above normal and directionally bullish | Markets Insider

Novavax Inc
Webhose 2025 Feb 20, 00:00

Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? - February 20, 2025 - Zacks.com

Novavax Inc
Webhose 2025 Feb 20, 00:00

Novavax (NVAX) Declines More Than Market: Some Information for Investors - February 20, 2025 - Zacks.com

Novavax Inc
Webhose 2025 Feb 19, 10:16

Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of "Hold" by Brokerages

Novavax Inc
Webhose 2025 Feb 19, 08:55

Novavax (NVAX) to Release Quarterly Earnings on Wednesday

Novavax Inc
Webhose 2025 Feb 19, 00:00

Novavax to Report Q4 Earnings: Here's What You Can Expect - February 19, 2025 - Zacks.com

Novavax Inc
Webhose 2025 Feb 15, 06:12

Novavax, Inc. (NASDAQ:NVAX) Receives $17.83 Consensus PT from Brokerages

Novavax Inc
Webhose 2025 Feb 12, 06:25

Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Brokerages

Novavax Inc
Webhose 2025 Feb 10, 00:00

Novavax (NVAX) Outperforms Broader Market: What You Need to Know - February 10, 2025 - Zacks.com

Novavax Inc
Webhose 2025 Feb 04, 00:00

Novavax (NVAX) Rises But Trails Market: What Investors Should Know - February 4, 2025 - Zacks.com

Novavax Inc
Webhose 2025 Feb 02, 00:44

Novavax (NASDAQ:NVAX) Stock Price Down 5.7% - Should You Sell?

Novavax Inc
Webhose 2025 Feb 01, 13:18

FY2025 EPS Estimates for Novavax Increased by Zacks Research

Novavax Inc
Webhose 2025 Jan 31, 14:06

Zacks Research Has Positive Estimate for Novavax Q2 Earnings

Novavax Inc
Webhose 2025 Jan 30, 21:58

Novavax (NASDAQ:NVAX) Shares Down 5.7% - Here's Why

Novavax Inc
Webhose 2025 Jan 27, 11:59

Novavax, Inc. (NASDAQ:NVAX) is Shah Capital Management's 2nd Largest Position

Novavax Inc
Webhose 2025 Jan 27, 00:00

Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know - January 27, 2025 - Zacks.com

Novavax Inc

Latest news

Frances Wang 2025 Feb 24, 16:00

Cava stock price: Cava Group news and forecast

Learn how to invest in tech stocks with high growth potential for long-term gains.
Vanessa L 2025 Feb 24, 09:00

How to Invest in Tech Stocks Amid Nvidia Stock Market Cap Swings

NVDA Stocks Shares
Alibaba’s $52B AI investment drives global interest in investing in AI and cloud computing.
Vanessa L 2025 Feb 24, 03:50

Alibaba's $52B AI Investment Reshapes AI Market

Stocks Shares Tech
Space.Xia 2025 Feb 23, 16:00

Will the Federal Reserve Be Trapped? U.S. Stocks May Face a 10% Sell-Off in the Second Half of the Year!

Tommy Yap 2025 Feb 23, 16:00

Morning Note: Zoom Q4 Earnings, Eurozone Inflation & Oil Prices

Morning Note Oil
Tommy Yap 2025 Feb 22, 16:00

Week Ahead: Australia Inflation and US Core PCE Price Index in Focus

Forex Indices
Why did stock market drop today due to Walmart's economic outlook.
Vanessa L 2025 Feb 21, 06:40

Why Did Stock Market Drop Today? Walmart’s Forecast Sparks Economic Concerns

Frances Wang 2025 Feb 20, 16:00

Shiba inu news: What is happening to Shiba Inu today?

Cryptocurrencies

Info

Spread

0.05

Spread (%)

0.6793 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

14:31 - 20:59

Monday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1279878016

Shares Outstanding

160184992

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-2.18

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments
Trustpilot
Live Chat